3D Tracking for OCT Image Fusion in Gynecological Diagnosis

Information

  • Research Project
  • 8549122
  • ApplicationId
    8549122
  • Core Project Number
    R44CA141876
  • Full Project Number
    5R44CA141876-03
  • Serial Number
    141876
  • FOA Number
    PA-11-096
  • Sub Project Id
  • Project Start Date
    8/1/2009 - 15 years ago
  • Project End Date
    8/31/2015 - 9 years ago
  • Program Officer Name
    NARAYANAN, DEEPA
  • Budget Start Date
    9/1/2013 - 11 years ago
  • Budget End Date
    8/31/2015 - 9 years ago
  • Fiscal Year
    2013
  • Support Year
    03
  • Suffix
  • Award Notice Date
    8/28/2013 - 11 years ago
Organizations

3D Tracking for OCT Image Fusion in Gynecological Diagnosis

DESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to continue development of an exciting platform based on integration of optical coherence tomography acquisition with real-time 3D spatial localization. In Phase I, in the context of gynecological diagnostic imaging, we demonstrated hardware and software for prototype image fusion between colposcopic/intravaginal imaging and OCT images of the cervix. We also demonstrated a promising methodology for simplified acquisition of 3D OCT data sets which may have broad application. In this project, we build upon these promising results to define and develop two new products. The first will be a clinical tracking and software system which augments an OCT imaging system to provide fusion between OCT and colposcopic images as well as tools for analyzing, reviewing, and reporting image findings. The second will consist of software and an imaging/tracking probe which can be readily coupled (by an end user) to commercially available OCT systems and which, when installed, will allow reconstruction of 3D OCT datasets from simple manually scanned 2D data. Devices will be validated in phantoms and animal models as well as clinically. While this application continues to be focused on gynecological diagnosis, we will also lay important experimental groundwork for future development of this technology in other fields.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    436789
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:436789\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOTEX, INC.
  • Organization Department
  • Organization DUNS
    969792050
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77045
  • Organization District
    UNITED STATES